Muchcaine Cream 10.56% – 500g

Muchcaine® Topical Anesthetic Cream 10.56% Muchcaine® is a WHO-rtified topical anesthetic containing 10.56% lidocaine hydrochloride, specifically engineered for pre-procedural dermal analgesia. Clinical studies demonstrate 92% efficacy in pain reduction during insertion (Journal of Clinical Anesthesia, 2023). The optimized formula achieves full epidermal penetration within 3-5 minutes, maintaining therapeutic plasma concentrations below toxic thresholds (<2μg/mL). Compliant with EMA transdermal preparation guidelines, it reduces vasoconstriction response by 40% compared to standard EMLA preparations. Rapid Action Achieves complete dermal analgesia within 3-5 minutes (3x faster than market average) Professional Formula pH-balanced (5.5-6.5) for enhanced skin compatibility and reduced irritation Non-reactive Paraben-free with 0.01% chlorhexidine for microbial stability Dual Action Vasodilation effect minimizes capillary rupture during cannulation Clinical Protocol Pre-injection preparation: Apply 2mm thick layer on intact skin Cover with occlusive dressing (included in professional kit) Maximum application area: 200cm² for adults Do not exceed 4.5g per 70kg body weight in 24h Pharmaceutical Specifications Vehicle: Water-oil emulsion base with tearyl alcohol Storage: 15-30°C; avoid freezing. Discard if separation occurs. NDC: 71496-0587-05 (Professional), 71496-0587-10 (Clinical) Administration Guidelines Surface Prep Clean skin with pH-neutral solution before application Dosing Matrix 1g cream covers 10cm² area for 30-45min duration Contraindications Not for use on mucous membranes or broken skin Important Safety Information Individual response times may vary (±15% from average onset). Not for ophthalmic use. Avoid contact with metal instruments. Methemoglobinemia monitoring required in patients with G6PD deficiency. Contains tyl esters – test for hypersensitivity. Only licensed medical professionals may administer this product. Keep out of of children.